GBA Fund Investment Limited - Net Worth and Insider Trading
GBA Fund Investment Limited Net Worth
The estimated net worth of GBA Fund Investment Limited is at least $201 Million dollars as of 2024-06-22. GBA Fund Investment Limited is the 2101 Beneficial owner of ImmuneOnco Biopharmaceuticals (Shanghai) Inc and owns about 13,854,690 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) stock worth over $201 Million. Details can be seen in GBA Fund Investment Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that GBA Fund Investment Limited has not made any transactions after 2023-09-05 and currently still holds the listed stock(s).
Transaction Summary of GBA Fund Investment Limited
GBA Fund Investment Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, GBA Fund Investment Limited owns 1 companies in total, including ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) .
Click here to see the complete history of GBA Fund Investment Limited’s form 4 insider trades.
Insider Ownership Summary of GBA Fund Investment Limited
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HKSE:01541 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc | 2023-09-05 | 2101 Beneficial owner |
GBA Fund Investment Limited Latest Holdings Summary
GBA Fund Investment Limited currently owns a total of 1 stock. GBA Fund Investment Limited owns 13,854,690 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) as of September 5, 2023, with a value of $201 Million.
Latest Holdings of GBA Fund Investment Limited
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HKSE:01541 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc | 2023-09-05 | 13,854,690 | 14.48 | 200,615,911 |
Holding Weightings of GBA Fund Investment Limited
GBA Fund Investment Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, GBA Fund Investment Limited has made a total of 1 transactions in ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in ImmuneOnco Biopharmaceuticals (Shanghai) Inc is the sale of 13,854,690 shares on September 5, 2023, which brought GBA Fund Investment Limited around $0.
Insider Trading History of GBA Fund Investment Limited
- 1
GBA Fund Investment Limited Trading Performance
GBA Fund Investment Limited Ownership Network
Ownership Network List of GBA Fund Investment Limited
Ownership Network Relation of GBA Fund Investment Limited
![Insider Network Chart](https://static.gurufocus.com/insider-network.png)
GBA Fund Investment Limited Owned Company Details
What does ImmuneOnco Biopharmaceuticals (Shanghai) Inc do?
Who are the key executives at ImmuneOnco Biopharmaceuticals (Shanghai) Inc?
GBA Fund Investment Limited is the 2101 Beneficial owner of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. Other key executives at ImmuneOnco Biopharmaceuticals (Shanghai) Inc include Ho Yao , CHENG YIQUAN , and 2102 Investment manager LAV Asset Management (Hong Kong) Limited .
ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) Insider Trades Summary
Over the past 18 months, GBA Fund Investment Limited made 1 insider transaction in ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) with a net sale of 0. Other recent insider transactions involving ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) include a net sale of 0 shares made by LAV GP V, L.P. , a net sale of 0 shares made by Halo Biomedical LP , and a net sale of 0 shares made by CHENG YIQUAN .
In summary, during the past 3 months, insiders sold 0 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541)'s detailed insider trading history can be found in Insider Trading Tracker table.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Insider Transactions
GBA Fund Investment Limited Mailing Address
Above is the net worth, insider trading, and ownership report for GBA Fund Investment Limited. Currently GuruFocus does not have mailing address information for GBA Fund Investment Limited.